Citation Impact
Citing Papers
Vertebral Fracture Assessment (VFA) With a Densitometer Predicts Future Fractures in Elderly Women Unselected for Osteoporosis
2008
Renal expression of parvalbumin is critical for NaCl handling and response to diuretics
2007
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
2011
Breast cancer
2019 Standout
The clinician’s guide to prevention and treatment of osteoporosis
2022
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
2012
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary
2016
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Health benefits of physical activity: the evidence
2006 Standout
Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis
2011
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Osteoporosis
2019 Standout
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics
2011 Standout
Review article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease
2011
A proteomic atlas of senescence-associated secretomes for aging biomarker development
2020 Standout
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
1999
Inflammation Is The Main Determinant of Low Bone Mineral Density in Pediatric Inflammatory Bowel Disease
2006
Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK
2008
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Vertebral Fracture Assessment: The 2005 ISCD Official Positions
2006
OARSI guidelines for the non-surgical management of knee osteoarthritis
2014 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
The Helix-II epitope: a cautionary tale from a cartilage biomarker based on an invalid collagen sequence
2009
Crohn's disease
2012 Standout
Strontium Ranelate Enhances Callus Strength More Than PTH 1-34 in an Osteoporotic Rat Model of Fracture Healing
2009
A Proposed Classification of Ileal Pouch Disorders and Associated Complications After Restorative Proctocolectomy
2008
Vitamin D Deficiency
2007 Standout
Assessment of hand trabecular bone texture with high resolution direct digital radiograph in rheumatoid arthritis: A case control study
2011
ESHRE guideline: management of women with endometriosis
2014 Standout
A Single Dose of Intravenous Zoledronate Prevents Glucocorticoid Therapy-Associated Bone Loss in Acute Flare of Crohn's Disease, a Randomized Controlled Trial
2011
Review of bioactive glass: From Hench to hybrids
2012 Standout
The risks of PPI therapy
2012
Osteoporosis: now and the future
2011 Standout
FRAX® with and without Bone Mineral Density
2011
Osteoarthritis
2015 Standout
ESHRE guideline for the diagnosis and treatment of endometriosis
2005 Standout
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
2011
Treatment of Postmenopausal Osteoporosis
1998
A Double-Blind Placebo-Controlled Study of Intravenous Clodronate for Prevention of Steroid-Induced Bone Loss in Inflammatory Bowel Disease
2007
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
2010 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Extracellular matrix structure
2015 Standout
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Prevention and treatment of osteoporosis in inflammatory bowel disease
2006
Biological markers in osteoarthritis
2012
A systematic review of diagnostic accuracy of vertebral fracture assessment (VFA) in postmenopausal women and elderly men
2016
Mice chronically fed a westernized experimental diet as a model of obesity, metabolic syndrome and osteoporosis
2006
Drug repurposing: progress, challenges and recommendations
2018 Standout
Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumab
2013
AGA technical review on osteoporosis in gastrointestinal diseases
2003
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Imminent fracture risk
2017
Noncanonical Wnt signaling promotes osteoclast differentiation and is facilitated by the human immunodeficiency virus protease inhibitor ritonavir
2011
Remodelling the extracellular matrix in development and disease
2014 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Comparative Analysis of the Radiology of Osteoporotic Vertebral Fractures in Women and Men: Cross-Sectional and Longitudinal Observations from the Canadian Multicentre Osteoporosis Study (CaMos)
2017
Sarcopenia
2019 Standout
Epidemiology of Vertebral Fractures
2015
Endometriosis
2010 Standout
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
2009
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 1: Hip Geometry
2015
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
2003 Standout
The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss
2005
Ulcerative colitis
2020 Standout
Quantitative imaging techniques for the assessment of osteoporosis and sarcopenia
2018
Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease
2000
Management of Crohn's Disease in Adults
2009 Standout
Trabecular Bone Score
2016
Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies
2004
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin‐6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double‐blind, placebo‐controlled trial of tocilizumab in inadequate responders to methotrexate alone
2009
A systematic review of intervention thresholds based on FRAX
2016
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016
2016
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: The manitoba study
2011
Osteoporotic Vertebral Fracture Prevalence Varies Widely Between Qualitative and Quantitative Radiological Assessment Methods: The Rotterdam Study
2017
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
2010
Considerations for Development of Surrogate Endpoints for Antifracture Efficacy of New Treatments in Osteoporosis: A Perspective
2008
Magnesium in Man: Implications for Health and Disease
2014 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Materials characterisation and cytotoxic assessment of strontium-substituted bioactive glasses for bone regeneration
2010
Breast Cancer Survivorship: A Comprehensive Review of Long-Term Medical Issues and Lifestyle Recommendations
2015
Effects of Risedronate on Osteoarthritis of the Knee
2010
The extracellular matrix at a glance
2010 Standout
Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density
2003
Screening for Osteoporosis: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation
2010
Systematic review: hypomagnesaemia induced by proton pump inhibition
2012
An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women
2010
HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: beneficial effect of pravastatin
2013
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
2012
Prevention and treatment of osteoporosis in patients with inflammatory bowel disease
1999
Compression fractures detection on CT
2017
The Metabolic Syndrome
2008 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Clinical Applications of Vertebral Fracture Assessment by Dual-Energy X-Ray Absorptiometry
2006
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine
2014
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Quantitative Ultrasound Techniques for the Assessment of Osteoporosis: Expert Agreement on Current Status
1997
Algorithm-Based Qualitative and Semiquantitative Identification of Prevalent Vertebral Fracture: Agreement Between Different Readers, Imaging Modalities, and Diagnostic Approaches
2007
Maternal-Fetal Calcium and Bone Metabolism During Pregnancy, Puerperium, and Lactation*
1997
Works of S. Kolta being referenced
Vertebral fracture risk reduction with strontium ranelate in women with post-menopausal osteoporosis is independent of baseline risk factors
2006
Effects of strontium ranelate on spinal osteoarthritis progression
2007
Vertebral dimensions as risk factor of vertebral fracture in osteoporotic patients: a systematic literature review
2007
Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: The OPUS study
2013
Bone texture analysis of human femurs using a new device (BMA™) improves failure load prediction
2011
Volumetric quantitative computed tomography of the proximal femur: relationships linking geometric and densitometric variables to bone strength. Role for compact bone
2006
Bone Mineral Measurements in Mice
2003
In vivo 3D reconstruction of human vertebrae with the three-dimensional X-ray absorptiometry (3D-XA) method
2007
Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin
1995
Bone loss in patients with inflammatory bowel disease: A prospective study
1995
Identification of Rheumatoid Arthritis Patients With Vertebral Fractures Using Bone Mineral Density and Trabecular Bone Score
2012
Follow-up of Individual Patients on Two DXA Scanners of the Same Manufacturer
2000
Clinical evaluation of spine morphometric X-ray absorptiometry
1998
Increase in Vertebral Fracture Risk in Postmenopausal Women Using Omeprazole
2008
Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients
2009
TBS result is not affected by lumbar spine osteoarthritis
2014
Metabolic bone assessment in patients with inflammatory bowel disease
1995
Mild prevalent and incident vertebral fractures are risk factors for new fractures
2007
Adjusting FRAX® on TBS for identification of subjects at high risk of fractures
2017
2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis
2012
Diagnosis of Vertebral Fractures by Vertebral Fracture Assessment
2006
Added value of trabecular bone score over bone mineral density for identification of vertebral fractures in patients with areal bone mineral density in the non-osteoporotic range
2013
Radiographic methods for evaluating osteoporotic vertebral fractures
2009
Vertebral Fracture Risk Reduction With Strontium Ranelate in Women With Postmenopausal Osteoporosis Is Independent of Baseline Risk Factors
2006
Association of Five Quantitative Ultrasound Devices and Bone Densitometry With Osteoporotic Vertebral Fractures in a Population-Based Sample: The OPUS Study
2004
Inactivation of theNa-Cl Co-Transporter(NCC) Gene Is Associated With High BMD Through Both Renal and Bone Mechanisms: Analysis of Patients With Gitelman Syndrome andNccNull Mice
2005
Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy.
2008
Long-Term Safety of Fluticasone Propionate and Nedocromil Sodium on Bone in Children With Asthma
2003
Broadband ultrasound attenuation imaging: A new imaging method in osteoporosis
1996